0
Special Reports |

Pro/Con Debate: Lung Allocation Should Be Based on Medical Urgency and Transplant Survival and Not on Waiting Time*

Thomas M. Egan, MD, MSc; Robert M. Kotloff, MD, FCCP
Author and Funding Information

*From the Section of Advanced Lung Disease and Lung Transplantation (Dr. Kotloff), Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, PA; and the Lung Allocation Subcommittee of the Thoracic Organ Transplantation Committee (Dr. Egan), United Network for Organ Sharing, and the Division of Cardiothoracic Surgery, University of North Carolina, Chapel Hill, NC.

Correspondence to: Robert M. Kotloff, MD, 838 West Gates, University of Pennsylvania Medical Center, 3400 Spruce St, Philadelphia, PA 19027, e-mail: kotloff@mail.med.upenn.edu or to Thomas M. Egan, MD, Division or Cardiothoracic Surgery, UNC-Chapel Hill, CB 7065, Chapel Hill, NC 27599-7065; e-mail: ltxtme@med.unc.edu



Chest. 2005;128(1):407-415. doi:10.1378/chest.128.1.407
Text Size: A A A
Published online

Extract

1. U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients. (2004)2003 Annual Report of the U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients. U.S. Department of Health and Human Services/Health Resources and Services Administration (HHS/HRSA)/United Network for Organ Sharing (UNOS). Rockville, MD/Richmond, VA: 2The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation (ISHLT).. International guidelines for the selection of lung transplant candidates.Am J Respir Crit Care Med1998;158,335-3393Department of Health and Human Services. Organ Procurement and Transplantation Network: final rule; 42 CFR—Part 121. Federal Register, October 20, 1999; 56649–566614Committee on Organ Procurement and Transplantation Policy, Division of Health Sciences Policy, Institute of Medicine.. Organ procurement and transplantation: assessing current policies and the potential impact of the DHHS final rule.1999 National Academy Press. Washington, DC: 5Egan, T Ethical issues in thoracic organ distribution for transplant.Am J Transplant2003;3,366-3726Hosenpud, JD, Bennett, LE, Keck, BM, et al Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.Lancet1998;351,24-277Hadorn, D Setting health care priorities in Oregon: cost effectiveness meets the rule of rescue.JAMA1991;265,2218-22258Jonsen, A Bentham in a box: technology assessment and health care allocation.Law Med Health Care1986;14,172-1749United Network for Organ Sharing.. UNOS Update.1994 United Network for Organ Sharing (UNOS). Richmond, VA: 10Childress J. The gift of life: ethical issues in organ transplantation; ACS Regents Committee on Ethics—1995 Ethics and Philosophy Lecture. Available at: http://www.facs.org/education/ethics/childresslect.html. Accessed August 20, 200411Egan, TM, Bennett, LE, Garrity, ER, et al Are there predictors of death at the time of listing for lung transplant [abstract]?J Heart Lung Transplant2002;21,15412Egan, T, McCullough, K, Murray, S, et al Risk factors for death after lung transplant in the U.S. [abstract].J Heart Lung Transplant2003;22,S146-S14713Organ Procurement and Transplantation Network. Policy 3.7: Allocation of Thoracic Organs (revised June 25, 2004). Available at: http://www.optn.org/PoliciesandBylaws/policies/pdfs/policy_9.pdf. Accessed December 29, 200414Liou, TG, Adler, FR, Fitzsimmons, SC, et al Predictive 5-year survivorship model of cystic fibrosis.Am J Epidemiol2001;153,345-35215Kerem, E, Reisman, J, Corey, M, et al Prediction of mortality in patients with cystic fibrosis.N Engl J Med1992;326,1187-119116D’Alonzo, GE, Barst, RJ, Ayres, SM, et al Survival in patients with primary pulmonary hypertension: results from a national prospective registry.Ann Intern Med1991;115,343-34917McMullen, LE Equitable allocation of human organs: an examination of the new federal regulation.J Leg Med1999;20,405-42418Egan, TM, Lambert, CJ, Jr, Reddick, RL, et al A strategy to increase the donor pool: the use of cadaver lungs for transplantation.Ann Thorac Surg1991;52,1113-112119Egan, T Non-heart beating donors in thoracic transplantation.J Heart Lung Transplant2004;23,3-1020Steen, S, Sjoberg, T, Pierre, L, et al Transplantation of lungs from a non-heart beating donor.Lancet2001;357,825-82921Varela, A Are out hospital non heart beating donors (NHBD) better than brain death lung donors [abstract]?.J Heart Lung Transplant2004;23,S8722Hosenpud, JD, Bennett, LE, Keck, BM, et al Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease.Lancet1998;351,24-2723United Network for Organ Sharing. Policy 3.7: organ distribution; allocation of thoracic organs. Available at: http://www.unos.org/policiesandbylaws/policies.asp?resources=true. Accessed June 20, 200524Braitman, LE, Davidoff, F Predicting clinical states in individual patients.Ann Intern Med1996;125,406-41225Justice, AC, Covinsky, KE, Berlin, JA Assessing the generalizability of prognostic information.Ann Intern Med1999;130,515-52426McGinn, TG, Guyatt, GH, Wyer, PC, et al Users’ guides to the medical literature: XXII. How to use articles about clinical decision rules: Evidence-Based Medicine Working Group.JAMA2000;284,79-8427Malinchoc, M, Kamath, PS, Gordon, FD, et al A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology2000;31,864-87128Kamath, PS, Wiesner, RH, Malinchoc, M, et al A model to predict survival in patients with end-stage liver disease.Hepatology2001;33,464-47029Merion, RM, Wolfe, RA, Dykstra, DM, et al Longitudinal assessment of mortality risk among candidates for liver transplantation.Liver Transpl2003;9,12-1830Wiesner, R, Edwards, E, Freeman, R, et al Model for end-stage liver disease (MELD) and allocation of donor livers.Gastroenterology2003;124,91-9631Kerem, E, Reisman, J, Corey, M, et al Prediction of mortality in patients with cystic fibrosis.N Engl J Med1992;326,1187-119132Maurer, JR, Frost, AE, Estenne, M, et al International guidelines for the selection of lung transplant candidates.J Heart Lung Transplant1998;17,703-70933Doershuk, CF, Stern, RC Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1may adversely affect overall survival.Chest1999;115,782-78734Milla, CE, Warwick, WJ Risk of death in cystic fibrosis patients with severely compromised lung function.Chest1998;113,1230-123435Liou, TG, Adler, FR, Fitzsimmons, SC, et al Predictive 5-year survivorship model of cystic fibrosis.Am J Epidemiol2001;153,345-35236Mayer-Hamblett, N, Rosenfeld, M, Emerson, J, et al Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.Am J Respir Crit Care Med2002;166,1550-155537Vizza, CD, Yusen, RD, Lynch, JP, et al Outcome of patients with cystic fibrosis awaiting lung transplantation.Am J Respir Crit Care Med2000;162,819-82538De, Meester J, Smits, JM, Persijn, GG, et al Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience.J Heart Lung Transplant2001;20,518-52439Ouwens, JP, Groen, H, TenVergert, EM, et al Simulated waiting list prioritization for equitable allocation of donor lungs.J Heart Lung Transplant2002;21,797-80340Hopkins, WE, Ochoa, LL, Richardson, GW, et al Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.J Heart Lung Transplant1996;15,100-10541Trulock, EP, Edwards, LB, Taylor, DO, et al The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004.J Heart Lung Transplant2004;23,804-815

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543